Filters
Other countries
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
Invitae Metabolic Newborn Screening Confirmation Panel Labcorp Genetics (formerly Invitae) LabCorp United States | 201 | 158 |
|
Labcorp Genetics (formerly Invitae) LabCorp United States | 466 | 297 |
|
Aicardi-Goutières Syndrome Panel PreventionGenetics, part of Exact Sciences United States | 7 | 7 |
|
Leukodystrophy and leukoencephalopathy panel. NGS panel of 74 genes. Genologica Medica Spain | 96 | 74 |
|
Aicardi-Goutières Syndrome Panel Genologica Medica Spain | 13 | 7 |
|
Epileptic encephalopathy panel. 128-gene NGS panel. Genologica Medica Spain | 197 | 128 |
|
Retinal dystrophy panel. 260 gene NGS panel. Genologica Medica Spain | 420 | 257 |
|
Complete epilepsy panel. NGS panel of 283 genes. Genologica Medica Spain | 409 | 283 |
|
Aicardi-Goutieres syndrome: Full gene sequencing panel CEN4GEN Institute for Genomics and Molecular Diagnostics Canada | 8 | 8 |
|
Aicardi-Goutieres syndrome type 1 Bioarray Spain | 1 | 1 |
|
Comprehensive Metabolism NGS Panel Fulgent Genetics United States | 602 | 355 |
|
Fulgent Genetics United States | 354 | 210 |
|
Comprehensive Primary Immunodeficiency NGS Panel Fulgent Genetics United States | 1048 | 472 |
|
Hereditary Spastic Paraplegia NGS Panel Greenwood Genetic Center Diagnostic Laboratories Greenwood Genetic Center United States | 81 | 79 |
|
Epilepsy Advanced Sequencing and CNV Evaluation-Epileptic Encephalopathy Athena Diagnostics United States | 66 | 67 |
|
Epilepsy Advanced Sequencing and CNV Evaluation Athena Diagnostics United States | 233 | 234 |
|
Laboratorio de Genetica Clinica SL Spain | 7 | 7 |
|
Leukodystrophy / Leukoencephalopathy Panel CeGaT GmbH Germany | 8 | 76 |
|
Epilepsy Comprehensive NGS Panel Fulgent Genetics United States | 729 | 398 |
|
Syndromes with immunodeficiency Panel CeGaT GmbH Germany | 33 | 38 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.